Ccu, National university in Minxiong, Chiayi, Taiwan

New York, June 26 Antacids improved blood sugar control in people with diabetes but had no effect on reducing the risk of diabetes in the general population, according to a new study.Type-2 diabetes is a global public health concern affecting almost 10 per cent of people worldwide. Doctors may prescribe diet and lifestyle changes, diabetes medications, or insulin to help people with diabetes better manage their blood sugar, but recent data points to common over the counter antacid medicines as another way to improve glucose levels."Our research demonstrated that prescribing antacids as an add-on to standard care was superior to standard therapy in decreasing hemoglobin A1c (HbA1c) levels and fasting blood sugar in people with diabetes," said study author Carol Chiung-Hui Peng, from the University of Maryland Medical Center in Baltimore."For people without diabetes, taking antacids did not significantly alter their risk of developing the disease," added Huei-Kai Huang from the Hualien Tzu Chi Hospital in Hualien, Taiwan.For the study, published in the Journal of Clinical Endocrinology & Metabolism, the team conducted a meta-analysis on the effects of proton pump inhibitors (PPIs) a commonly used type of antacid medication on blood sugar levels in people with diabetes and whether these medications could prevent the new onset of diabetes in the general population.The analysis included seven studies (342 participants) for glycemic control and 5 studies (244, 439 participants) for risk of incident diabetes. The researchers found antacids can reduce HbA1c levels by 0.36 per cent in people with diabetes and lower fasting blood sugar by 10 mg/dl based on the results from seven clinical trials.For those without diabetes, the results of the five studies showed that antacids had no effect on reducing the risk of developing diabetes."People with diabetes should be aware that these commonly used antacid medications may improve their blood sugar control, and providers could consider this glucose-lowering effect when prescribing these medications to their patients," said Kashif Munir, Associate Professor from the University of Maryland School of Medicine in Baltimore.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

CcuFOLLOW

Ccu, Latest News

Seoul, July 11 South Korean tech giant Samsung's supply chain partners and suppliers are preparing to develop vapour ... ...

Taipei, July 7 Taiwan's unemployment rate has increased to more than a seven year high of 4.11 per ... ...

In yet another intrusion by Beijing amid escalating tensions in Taiwan Strait, a Chinese warplane entered Taiwan's air defence identification zone (ADIZ), marking the second intrusion this month. ...

A seven-year-old boy died after he was slammed 27 times during a judo practice class. The boy, who was ... ...

A 17-year-old boy was brought to Billroth Hospitals, run over by a bus when he tried to alight from it. The boy was in septic shock status during his arrival. ...

Hsinchu (Taiwan), June 29 Chipset maker MediaTek on Tuesday unveiled the 'Dimensity 5G Open Resource Architecture' that provides ... ...

Taiwan Health Minister Chen Shih-chung on Monday informed that more 410,000 doses of the Moderna COVID-19 vaccine will be delivered to Taiwan on June 30 amid growing tensions between the island and China. ...

New York, June 26 Antacids improved blood sugar control in people with diabetes but had no effect on ... ...